Symptoms Experience and Quality of Life in The Patients With Breast Cancer Receiving The Taxane Class of Drugs
Objective: The aim of this study is to evaluate the symptoms experience and quality of life in patients with breast cancer receiving the taxane class of drugs.Materials and Methods: This study was performed between November 2015 March 2016 in a chemotherapy unit of a university hospital with 48 pati...
Main Authors: | Kamile Kırca, Sevinç Kutlutürkan |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Publishing House
2018-07-01
|
Series: | European Journal of Breast Health |
Subjects: | |
Online Access: |
http://www.eurjbreasthealth.com/archives/archive-detail/article-preview/symptoms-experience-and-quality-of-life-in-the-pat/42037
|
Similar Items
-
Taxane-induced acute interstitial pneumonitis in patients with breast cancer and outcome of taxane rechallenge
by: T M Anoop, et al.
Published: (2022-01-01) -
New possibilities of chemotherapy for anthracyclineand/or taxane-resistant breast cancer
by: E V Artamonova, et al.
Published: (2013-06-01) -
Breast Cancer: Clinical–Epidemiological Profile and Toxicities of Women Receiving Treatment with Taxanes in the Amazon Region
by: Marta Solange Camarinha Ramos Costa, et al.
Published: (2023-09-01) -
Long Noncoding RNAs in Taxane Resistance of Breast Cancer
by: Hailong Chen, et al.
Published: (2023-07-01) -
Outcomes of Triple-Negative Breast Cancer Patients in Response to Taxane and Nontaxane-Based Neoadjuvant Chemotherapies
by: Mohsin Khan, et al.
Published: (2022-06-01)